Moulton, Calum D. https://orcid.org/0000-0003-0880-4495
Malys, Mantas
Hopkins, Christopher W. P.
Rokakis, Anna S.
Young, Allan H.
Powell, Nick
Funding for this research was provided by:
NIHR Maudsley Biomedical Research Centre
NIHR Imperial Biomedical Research Centre
National Institute for Health and Care Research (NIHR Advanced Fellowship)
Article History
Received: 4 May 2024
Accepted: 3 July 2024
First Online: 16 July 2024
Declarations
:
: C.D.M. has given paid educational talks for AbbVie, Dr Falk Pharma UK Ltd and Takeda. C.D.M. is funded by a National Institute for Health and Care Research (NIHR) Advanced Fellowship. N.P. has been speaker, advisory consultant or has received research grants from AbbVie, Allergan, Astra-Zeneca, Bristol-Myers Squibb, Celgene, Celltrion, Dr Falk Pharma UK Ltd, Ferring, Galapagos, GSK, Janssen, Roche, Pfizer, Sobi, Takeda, Tillotts and Vifor. N.P. is funded by the Wellcome Trust. A.H.Y. has served as a consultant, advisory board member or speaker for Flow Neuroscience, Novartis, Roche, Janssen, Takeda, Noema Pharma, Compass, AstraZeneca, Boehringer Ingelheim, Eli Lilly, LivaNova, Lundbeck, Sunovion, Servier, Janssen, Allegan, Bionomics, Sumitomo Dainippon Pharma, Sage and Neurocentrx. For the remaining authors, there are no conflicts of interest.